2026-05320
Proposed RuleMedical Devices; Radiology Devices; Classification of Blood Irradiators
Introduced: March 18, 2026
Progress
Summary
The Food and Drug Administration (FDA) is proposing to classify blood irradiator devices (product code MOT), unclassified preamendments devices, as follows: blood irradiator devices intended to prevent transfusion-associated graft-versus-host disease into class II (special controls) with premarket notification and blood irradiator devices intended to prevent metastasis into class III (premarket approval) to provide a reasonable assurance of safety and effectiveness of these devices. Elsewhere in this issue of the Federal Register, FDA is issuing a proposed order proposing to require the filing of a premarket approval application for blood irradiator devices intended to prevent metastasis.
How This Affects You
Related Bills
Get personalized insights on this bill
CivicRadar tells you exactly how government actions affect your life based on your location, interests, and profession.